Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    savita thakur thakur
    savita thakur thakur
      • Home
      • savita thakur thakur

      Articles By : savita thakur thakur

      Dr Reddy

      Dr Reddy's Recalls 50k Bottles of Ondansetron Tabs in US

      savita thakur thakur20 May 2016 3:03 PM IST
      New Delhi : Drug firm Dr Reddy's Laboratories is recalling over 50,000 bottles of Ondansetron tablets made at the company's Bachupally plant in India,...
      Colombia Battles NOVARTIS to reduce the price of its Monopoly Cancer Drug

      Colombia Battles NOVARTIS to reduce the price of its Monopoly Cancer Drug

      savita thakur thakur19 May 2016 1:54 PM IST
      Colombia : Colombia's government is giving pharmaceutical giant Novartis a few weeks to lower prices on a popular cancer drug or see its monopoly on...
      Novartis Breast Cancer Drug Set to Take on Pfizers Ibrance, Assuming 2018 Launch

      Novartis Breast Cancer Drug Set to Take on Pfizer's Ibrance, Assuming 2018 Launch

      savita thakur thakur19 May 2016 12:48 PM IST
      A clinical trial testing an experimental breast cancer pill from Novartis has been stopped early because of good results, boosting the Swiss company's...
      Government Approves FDI Proposals of Wockhardt, Aurobindo Pharma

      Government Approves FDI Proposals of Wockhardt, Aurobindo Pharma

      savita thakur thakur19 May 2016 12:47 PM IST
      New Delhi : The Foreign Investment Promotion Board (FIPB) has approved Rs.60.73 crore worth of foreign direct investment (FDI) proposals of Wockhardt,...
      South Africas Aspen Pharmacare signs US Supply Deal With ANI

      South Africa's Aspen Pharmacare signs US Supply Deal With ANI

      savita thakur thakur19 May 2016 9:47 AM IST
      Johannesburg : Aspen Pharmacare has signed a distribution and supply agreement with ANI Pharmaceuticals to sell a female cancer treatment in the...
      Strides Shasun plans to divest British subsidiary for Rs 240 crore

      Strides Shasun plans to divest British subsidiary for Rs 240 crore

      savita thakur thakur18 May 2016 3:56 PM IST
      New Delhi : Drug firm Strides Shasun has decided to divest the company's UK arm Shasun Pharma Solutions Ltd to its current management for an...
      Pharma Exports to witness a steep fall in terms of growth:Crisil

      Pharma Exports to witness a steep fall in terms of growth:Crisil

      savita thakur thakur18 May 2016 12:59 PM IST
      Mumbai : The pharmaceutical sector is heading for a tough time as exports growth in formulations (in US dollar terms) is expected to almost halve to...
      USFDA approval for Aurobindo Pharmas Hydromorphone Hydrochloride tablets

      USFDA approval for Aurobindo Pharma's Hydromorphone Hydrochloride tablets

      savita thakur thakur18 May 2016 12:53 PM IST
      Aurobindo Pharma Limited has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Hydromorphone...
      Fosun Pharmaceuticals non-binding proposal to buy Gland Pharma

      Fosun Pharmaceutical's non-binding proposal to buy Gland Pharma

      savita thakur thakur18 May 2016 12:41 PM IST
      Hong Kong : Shanghai Fosun Pharmaceutical (Group) Co has made a non-binding proposal to buy India's Gland Pharma, which is backed by KKR and valued at...
      Ratan Tata invests in MUrgency

      Ratan Tata invests in MUrgency

      savita thakur thakur18 May 2016 12:38 PM IST
      New Delhi : Tata Sons Chairman Emeritus Ratan Tata has invested in San Francisco-based medical emergency response startup MUrgency Inc.Financial...
      Eczema Therapies to get a fresh lease of life with Pfizer

      Eczema Therapies to get a fresh lease of life with Pfizer's Anacor Deal

      savita thakur thakur18 May 2016 12:16 PM IST
      New York : Pfizer Inc's purchase of Anacor Pharmaceuticals Inc heralds an approaching wave of potentially safer and more effective treatments for...
      Novartis Splits Drugs Business Into Two, Pharma Chief to Leave

      Novartis Splits Drugs Business Into Two, Pharma Chief to Leave

      savita thakur thakur18 May 2016 9:56 AM IST
      Zurich : Novartis is splitting its pharmaceuticals division into two business units, one focused on cancer medicines and the second on other drugs, it...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok